Showing results (541-550 of 807) with videos related to
Sort By:
Pageof 81
Neuropharmacology|July 14, 2009
Salvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residenceJacob M Hooker, Thomas A Munro, Cécile Béguin, et al.Oncoscience|January 17, 2015
Expression of Cancer/Testis genes in ductal carcinoma in situ and benign lesions of the breastOtavia L Caballero, Sami Shousha, Qi Zhao, et al.Biofilm|March 27, 2023
An integrated transcriptomic and metabolomic approach to investigate the heterogeneous Candida albicans biofilm phenotypeChristopher Delaney, Bryn Short, Ranjith Rajendran, et al.International Journal of Geriatric Psychiatry|March 23, 2019
Stressful life events and cognitive decline: Sex differences in the Baltimore Epidemiologic Catchment Area Follow-Up StudyCynthia A Munro, Alexandra M Wennberg, Nicholas Bienko, et al.QJM : Monthly Journal of the Association of Physicians|February 22, 2008
A pilot study of combination anti-cytokine and anti-lymphocyte biological therapy in rheumatoid arthritisA W Morgan, G Hale, P R U B Rebello, et al.Biomaterials|February 19, 2021
Spider silk nerve graft promotes axonal regeneration on long distance nerve defect in a sheep modelT Kornfeld, J Nessler, C Helmer, et al.British Journal of Haematology|March 1, 1986
Successful haploidentical mismatched bone marrow transplantation in severe combined immunodeficiency: T cell removal using CAMPATH-I monoclonal antibody and E-rosettingG Morgan, D C Linch, L T Knott, et al.British Journal of Haematology|May 3, 2000
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicityG M Cull, A P Haynes, J L Byrne, et al.Transplantation|June 9, 1999
Epstein-Barr virus (EBV) associated B-cell lymphoproliferative disease following HLA identical sibling marrow transplantation for aplastic anaemia in a patient with an EBV seronegative donorN Parry-Jones, T Haque, M Ismail, et al.Transplantation|October 27, 1996
CD4 mAbs prevent progression of alloactivated CD4+ T cells into the S phase of the cell cycle without interfering with early activation signalsS Fournel, C Vincent, O Assossou, et al.Pageof 81